November 9, 2023
General Counsel’s Internal Investigations Decision Tree for the Healthcare Industry
November 1, 2023
President Biden's Executive Order on AI - Legal Practice Snapshots
October 23, 2023
How Int'l Regulatory Collabs Can Expedite Pharma Approvals
October 16, 2023
Potential Broader Effects Of FDA's Lab-Developed Test Rule
September 25, 2023
Health Headlines – September 25, 2023
August 24, 2023
FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trials
August 10, 2023
FTC Revamps the “Guides Concerning the Use of Endorsements and Testimonials in Advertising”
July 27, 2023
FDA’s Much Anticipated New Cell and Gene Therapy Guidance Outlines a Conservative Approach to Manufacturing Changes
July 12, 2023
A Pathway for Medicare Coverage for Breakthrough Devices: Take Two
July 6, 2023
Mitigating Risks Of Developing Drugs And Devices With AI
July 6, 2023
EUROPE – New Interim Guidance on Parallel EMA-HTA Body Scientific Advice
June 30, 2023
FDA Finalizes Guidance on Presenting Quantitative Efficacy and Risk Information in DTC Promotion